CC BY 4.0 · Arq Neuropsiquiatr 2024; 82(S 02): S53-S176
DOI: 10.1055/s-0045-1806975
ID: 551
Area: Others
Presentation method: Eletronic Poster

Case report: Parry-Romberg syndrome

Renata Yasmin Cardoso Sousa
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Hugo Leonardo Justo Horácio
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Danielle Dutra Araújo
,
Olívia Sorato Bezerra
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Aline Da Costa Lourenço
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Gabriel De Lellis Neto
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Michele Michelin Becker
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
,
Josiane Ranzan Josemar Marchezan
1   Hospital de Clínicas de Porto Alegre, Porto Alegre RS, Brazil.
› Author Affiliations
 

    *Correspondence: renatscsousa@gmail.com.

    Abstract

    Case Presentation: A 6-year-old male patient with a history of neurodevelopmental delay, autism spectrum disorder and epilepsy. He had facial asymmetry with reduced subcutaneous tissue with erythematous macules on the left hemiface, without involvement of the cranial nerves. Brain MRI showed a global increase in CSF spaces due to a moderate reduction in brain volume, more evident on the left, with a slight diffuse reduction in the thickness of the white matter, associated with a reduction in hippocampal volume. The patient's mother had a similar dermatological alteration, with progressive atrophy in the left hemiface, without etiological definition and had no associated neurologic symptoms.

    Discussion: Parry-Romberg Syndrome is a rare disease characterized by progressive facial hemiatrophy, which may be associated with other systemic alterations, mainly neurological. Neurologic symptoms include seizures, cerebral hemiatrophy, trigeminal neuralgia, hemiparesis ipsilateral to the facial lesion. There is still no etiology for this syndrome, but it is believed that it may be related to trauma, immunity and autoimmune disorders. It usually occurs in the first decade of life, with slow progression for 2 to 20 years, and after this period, a period of stabilization is reached. Diagnosis is based on clinical history and physical examination, as well as exclusion of other conditions.

    Final Comments: Early identification is important for intervention and proper management of affected patients in order to reduce the comorbidities that accompany these individuals. Immunosuppressive drugs may be considered in some patients, especially in cases of brain involvement.


    #

    Publication History

    Article published online:
    12 May 2025

    © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil